AstraZeneca Pharma India Announces Departures of Senior Leadership
AstraZeneca Pharma India Limited announced the resignation of two senior management personnel who will be pursuing career opportunities outside the company. The departures involve Mr. Ayush Kumar Agarwal and Ms. Shikha Mirchandani Chatrath.Mr. Ayush Kumar Agarwal, who served as Business Unit Director - Biopharmaceutical Business Unit, will conclude his handover period and be relieved of his duties by the close of business hours on June 12, 2026.
Separately, Ms. Shikha Mirchandani Chatrath, Director - Commercial Excellence, BD and Strategy, will complete her handover process and exit the organization by the close of business hours on August 3, 2026.
The company stated that it is currently in the process of identifying suitable replacements for both senior positions.
The details of the resignations are summarized below:
| Name | Designation | Reason for Change | Departure Date |
|---|---|---|---|
| Mr. Ayush Kumar Agarwal | Business Unit Director - Biopharmaceutical Business Unit | Resignation to pursue career outside the Company | June 12, 2026 |
| Ms. Shikha Mirchandani Chatrath | Director - Commercial Excellence, BD and Strategy | Resignation to pursue career outside the Company | August 3, 2026 |
ASTRAZEN Stock Price Movement
Shares of AstraZeneca Pharma India Limited are edging higher to ₹8709.5 as of 11:50 AM today, successfully rallying 0.90% in live trading. The stock is showing robust interest, with activity recorded on a volume of 5,068 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.